MSD makes obesity play in up to $2bn deal for Hansoh鈥檚 GLP-1RA asset
MSD could pursue 鈥渃ardiometabolic benefits beyond weight reduction鈥 for Hansoh鈥檚 weight loss pill.
MSD could pursue 鈥渃ardiometabolic benefits beyond weight reduction鈥 for Hansoh鈥檚 weight loss pill.
New hope for long-COVID patients: Longidaza boosts exercise tolerance and improves pulmonary function.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Novo Nordisk invests $1.2bn in new Denmark facility
Nobel laureates 鈥榮trongly urge鈥 Senate to oppose confirmation of RFK Jr
Vifor Pharma offers 拢23m to NHS to resolve CMA investigation
FDA shares new draft guidance for accelerated approval